Research summary ·
Fibro-Inflammatory Signaling, Fibrosis, and Microvascular Ischemia as Convergent Translational Substrates of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: A Systematic Review.
Written based on 1 research study on PubMed, searched on 5 Nov 2026.
What was studied
This review looked at why some people with hypertrophic cardiomyopathy die suddenly. The disease is called HCM. The review asked if inflammation, scarring and poor small-vessel blood flow work together. Together they could form a base for dangerous heart rhythms. The search ran from the start of each database to January 2026. Of 167 records, 37 full reports were assessed. In all, 11 studies were included.
What they found
Scarring, called fibrosis, was the most clinically mature marker. Poor blood flow in small vessels seemed to add to electrical instability. This was clearest in changed heart muscle. Lab and tissue studies pointed to inflammation and scarring programs. These involved active fibroblasts and changes around cells.
What it means for patients
The authors say the evidence supports a combined model. They say prospective studies with checked outcomes are needed. These must come before risk sorting for sudden death can use these layers.
Why it is not certain yet
Only 11 studies were included. The abstract gives no data on how many people died suddenly. The molecular findings come from lab and tissue studies. They are not tests in patients. The authors say these layers cannot yet refine risk sorting.
Source
Fibro-Inflammatory Signaling, Fibrosis, and Microvascular Ischemia as Convergent Translational Substrates of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: A Systematic Review.
PubMed · PMID 42867755We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Hypertrophic cardiomyopathy publications